Cargando…
EpCAM nuclear localization identifies aggressive Thyroid Cancer and is a marker for poor prognosis
BACKGROUND: Proteolytic cleavage of the extracellular domain (EpEx) of Epithelial cell adhesion molecule (EpCAM) and nuclear signaling by its intracellular oncogenic domain Ep-ICD has recently been implicated in increased proliferation of cancer cells. The clinical significance of Ep-ICD in human tu...
Autores principales: | Ralhan, Ranju, Cao, Jun, Lim, Terence, MacMillan, Christina, Freeman, Jeremy L, Walfish, Paul G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912862/ https://www.ncbi.nlm.nih.gov/pubmed/20579375 http://dx.doi.org/10.1186/1471-2407-10-331 |
Ejemplares similares
-
An Ep-ICD Based Index Is a Marker of Aggressiveness and Poor Prognosis in Thyroid Carcinoma
por: He, Helen C.-H., et al.
Publicado: (2012) -
Nuclear Ep-ICD Expression Is a Predictor of Poor Prognosis in “Low Risk” Prostate Adenocarcinomas
por: Assi, Jasmeet, et al.
Publicado: (2015) -
Immunohistochemical analysis based Ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinoma
por: Kunavisarut, Tada, et al.
Publicado: (2012) -
The detection of EpCAM(+) and EpCAM(–) circulating tumor cells
por: Wit, Sanne de, et al.
Publicado: (2015) -
Programmed Death - Ligand 1 Expression Distinguishes Invasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma from Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features
por: Fu, Guodong, et al.
Publicado: (2017)